AP
Asokan Periyaswamy
About Asokan Periyaswamy
Data last updated:
Asokan Periyaswamy is a Director at Kalanrix Pharma Private Limited (since 2023). The companies operate in Food and Beverages. Kalanrix Pharma Private Limited reported revenue of ₹27.7 Lakh (FY 2025). Earlier, Asokan Periyaswamy was a Director at Hindsiam Bevs Private Limited (2016–2017).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Kalanrix Pharma Private Limited U46497TN2023PTC161844 | Director | 11 Jul 2023 | 2023 | ₹27.7 Lakh (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Hindsiam Bevs Private Limited U15549KA2014PTC077166 | Director | 21 Mar 2016 | 2014 | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Asokan Periyaswamy
| Name | DIN | Company | Designation |
|---|---|---|---|
| Thandaythabhani Kavitha | 10235520 | Kalanrix Pharma Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Asokan Periyaswamy
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Asokan Periyaswamy
Asokan Periyaswamy currently holds 1 directorship: Kalanrix Pharma Private Limited (Director, since 11 Jul 2023, revenue ₹27.7 Lakh (FY 2025)).
Asokan Periyaswamy was first appointed on 21 Mar 2016 as Director at Hindsiam Bevs Private Limited. The most recent appointment on record is 11 Jul 2023 at Kalanrix Pharma Private Limited.
Asokan Periyaswamy held 1 earlier board appointment: Hindsiam Bevs Private Limited (Director, 21 Mar 2016 to 31 Dec 2017).
The current boards of Asokan Periyaswamy's companies include Thandaythabhani Kavitha (Kalanrix Pharma Private Limited).